Response to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25

Eur J Cancer. 2016 Jul:61:159-60. doi: 10.1016/j.ejca.2016.03.064. Epub 2016 Apr 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Kidney Neoplasms
  • Metformin*
  • Risk

Substances

  • Metformin